Company Coverage
Huationg Global (HUAGL SP): 1H26: Margin Pressure Expected To Ease; Recovery Ahead
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
S$0.555
S$0.88
+58.6%
S$1.23
Analyst
Highlights
- Huationg’s 1H26 revenue of S$198m (+64% yoy) exceeded our expectation by 10%, driven by a 58% surge in civil engineering revenue.
- 1H26 earnings of S$8.6m were below expectations, largely due to higher diesel/fuel costs. Going forward, 2H26 earnings and margins are expected to recover from fuel cost normalisation and re-imbursement.
- Maintain BUY with a lower target price of S$0.88, pegged to a lower 10x 2026F PE. Huationg trades at 6.3x 2026F PE, a 37% discount to peers.

Analysis
- Record-high revenue beat but saw cost headwinds. 1H26 revenue rose 64% yoy to S$197.8m, representing 60% of our full-year forecast. Gross
profit fell 9% yoy to S$19.1m largely due to higher diesel/fuel and material costs which compressed margins. Net profit was S$8.6m, down 5% yoy, below expectations and representing 39% of our full-year forecast. Gross margin dropped 7.8ppt to 9.7% while net profit margin fell 3.3ppt to 4.1%. We expect a recovery in margins in 2H26 as diesel/fuel costs normalise, and efficiency measures such as fleet upgrades, converting 100 tipper trucks to12-wheelers to double the load per trip should bring margin upside.
- Civil engineering drove record-high revenue; dormitory operations kicked off. By segment, civil engineering revenue increased 58% to
S$177.4m in 1H26 (1H25: S$112.1m), while its new management contract for a dormitory kicked off, contributing S$10.0m to top-line and slightly offsetting the lower civil engineering margins. Inland logistics grew 5% yoy, while sales of construction material grew 140% off a lower base.
- Fuel shock should ease, but not fully reverse in 2026. While 1H26 saw incremental diesel costs of about S$6m, roughly half is expected to be reimbursed by the government in 2H26, plus around S$3m in 3Q26 with a similar 50% reimbursement. We model 2026 gross margin at 13.0%, with 2H26 offsetting a weaker 1H26, but still well below 2025’s 16.5%.

Highlights
- Huationg’s 1H26 revenue of S$198m (+64% yoy) exceeded our expectation by 10%, driven by a 58% surge in civil engineering revenue.
- 1H26 earnings of S$8.6m were below expectations, largely due to higher diesel/fuel costs. Going forward, 2H26 earnings and margins are expected to recover from fuel cost normalisation and re-imbursement.
- Maintain BUY with a lower target price of S$0.88, pegged to a lower 10x 2026F PE. Huationg trades at 6.3x 2026F PE, a 37% discount to peers.

Analysis
- Record-high revenue beat but saw cost headwinds. 1H26 revenue rose 64% yoy to S$197.8m, representing 60% of our full-year forecast. Gross
profit fell 9% yoy to S$19.1m largely due to higher diesel/fuel and material costs which compressed margins. Net profit was S$8.6m, down 5% yoy, below expectations and representing 39% of our full-year forecast. Gross margin dropped 7.8ppt to 9.7% while net profit margin fell 3.3ppt to 4.1%. We expect a recovery in margins in 2H26 as diesel/fuel costs normalise, and efficiency measures such as fleet upgrades, converting 100 tipper trucks to12-wheelers to double the load per trip should bring margin upside.
- Civil engineering drove record-high revenue; dormitory operations kicked off. By segment, civil engineering revenue increased 58% to
S$177.4m in 1H26 (1H25: S$112.1m), while its new management contract for a dormitory kicked off, contributing S$10.0m to top-line and slightly offsetting the lower civil engineering margins. Inland logistics grew 5% yoy, while sales of construction material grew 140% off a lower base.
- Fuel shock should ease, but not fully reverse in 2026. While 1H26 saw incremental diesel costs of about S$6m, roughly half is expected to be reimbursed by the government in 2H26, plus around S$3m in 3Q26 with a similar 50% reimbursement. We model 2026 gross margin at 13.0%, with 2H26 offsetting a weaker 1H26, but still well below 2025’s 16.5%.

BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
S$0.555
S$0.88
+58.6%
S$1.23
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Our latest research

26 Aug 2026
WuXi Biologics (Cayman) (2269 HK): 1H26: Exceeds Expectations; Robust Demand Fuels Accelerated Growth

26 Aug 2026

